TP53 and cancer: We proved this hypothesis by showing that the miR-101-3p-mediated reduction in p53 levels was restored by USP47, and that the inhibition of cell proliferation by miR-101-3p was also rescued by the overexpression of USP47 in p53-positive cancer cells.